Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Texas High School Investigates Quran-and-Hijab Handouts as Parents Question Campus Access

A North Texas public high school is facing scrutiny after a video…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Missile Barrages and Cyber Warfare: Iran Publishes a “Multi-Front” War Plan Against the U.S.

Iranian state-aligned media has published what it describes as…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

U.S. Considers Offering Asylum to British Jews Amid Rising Antisemitism

A new report suggesting the U.S. could consider asylum for British…
Read more